| Cancer, obesity, diabetes, and antidiabetic drugs: is the fog clearing? AJ Klil-Drori, L Azoulay, MN Pollak Nature reviews Clinical oncology 14 (2), 85-99, 2017 | 216 | 2017 |
| Interventions for implementation of thromboprophylaxis in hospitalized patients at risk for venous thromboembolism SR Kahn, DR Morrison, G Diendéré, A Piché, KB Filion, AJ Klil‐Drori, ... Cochrane Database of Systematic Reviews, 2018 | 92 | 2018 |
| Androgen deprivation therapy for prostate cancer and the risk of venous thromboembolism AJ Klil-Drori, H Yin, V Tagalakis, A Aprikian, L Azoulay European urology 70 (1), 56-61, 2016 | 51 | 2016 |
| 15-Lipoxygenases in cancer: a double-edged sword? AJ Klil-Drori, A Ariel Prostaglandins & Other Lipid Mediators 106, 16-22, 2013 | 49 | 2013 |
| Activation of coagulation in amniotic fluid during normal human pregnancy G Sarig, AJ Klil-Drori, D Chap-Marshak, B Brenner, A Drugan Thrombosis research 128 (5), 490-495, 2011 | 35 | 2011 |
| Effectiveness of interventions for the implementation of thromboprophylaxis in hospitalised patients at risk of venous thromboembolism: an updated abridged Cochrane systematic … SR Kahn, G Diendéré, DR Morrison, A Piché, KB Filion, AJ Klil-Drori, ... BMJ open 9 (5), e024444, 2019 | 31 | 2019 |
| Temporal trends in outpatient management of incident pulmonary embolism and associated mortality AJ Klil-Drori, J Coulombe, S Suissa, A Hirsch, V Tagalakis Thrombosis Research 161, 111-116, 2018 | 21 | 2018 |
| Direct oral anticoagulants in end-stage renal disease AJ Klil-Drori, V Tagalakis Seminars in thrombosis and hemostasis 44 (04), 353-363, 2018 | 19 | 2018 |
| Androgen deprivation therapy and the risk of anemia in men with prostate cancer BM Hicks, AJ Klil-Drori, H Yin, L Campeau, L Azoulay Epidemiology 28 (5), 712-718, 2017 | 19 | 2017 |
| Androgen deprivation therapy and the incidence of inflammatory bowel disease in patients with prostate cancer AJ Klil-Drori, K Tascilar, H Yin, A Aprikian, A Bitton, L Azoulay American Journal of Epidemiology 184 (1), 15-22, 2016 | 17 | 2016 |
| 2017 Eberhard F. Mammen Award Announcements: Part II–Young Investigator Awards EJ Favaloro Seminars in Thrombosis and Hemostasis 44 (02), 081-088, 2018 | 12 | 2018 |
| Persistence with generic imatinib for chronic myeloid leukemia: a matched cohort study AJ Klil-Drori, H Yin, L Azoulay, M Harnois, MO Gratton, L Busque, ... haematologica 104 (7), e293, 2019 | 8 | 2019 |
| Serum organochlorines and non-Hodgkin lymphoma: A case-control study in Israeli Jews and Palestinians AJ Klil-Drori, G Kleinstern, RA Seir, L Choshen-Cohen, Z Abdeen, ... Chemosphere 213, 395-402, 2018 | 8 | 2018 |
| Early switch to second-line tyrosine kinase inhibitor in chronic myeloid leukemia patients failing to achieve early molecular response AJ Klil-Drori, H Yin, L Azoulay, M Harnois, MO Gratton, A Del Corpo, ... Network, 2017 | 8 | 2017 |
| Venous thromboembolism and renal impairment: insights from the SWIss Venous ThromboEmbolism Registry (SWIVTER) D Spirk, T Sebastian, M Banyai, JH Beer, L Mazzolai, T Baldi, D Aujesky, ... Seminars in thrombosis and hemostasis 45 (08), 851-858, 2019 | 7 | 2019 |
| Prolactin-elevating antipsychotics and the risk of endometrial cancer AJ Klil-Drori, H Yin, HA Abenhaim, GG du Fort, L Azoulay The Journal of Clinical Psychiatry 78 (6), 1273, 2017 | 6 | 2017 |
| 2019 Eberhard F. Mammen Award Announcements: Part II—Young Investigator Awards EJ Favaloro Seminars in Thrombosis and Hemostasis 46 (02), 105-113, 2020 | 4 | 2020 |
| External validation of aspect (algorithm for suspected pulmonary embolism confirmation and treatment) AJ Klil-Drori, D Prajapati, Z Liang, M Wang, D Toupin, L Alothman, E Lang, ... Medical Care 57 (8), e47-e52, 2019 | 4 | 2019 |
| Comparative effectiveness of generic imatinib and brand-name imatinib for the treatment of chronic myeloid leukemia AJ Klil-Drori, L Azoulay, H Yin, MO Gratton, M Harnois, I Chamakhi, ... Blood 126 (23), 2778, 2015 | 4 | 2015 |
| 2019 Eberhard F. Mammen Award Announcements: Part I—Most Popular Articles EJ Favaloro Seminars in Thrombosis and Hemostasis 45 (03), 215-224, 2019 | 3 | 2019 |
Susan R KahnProfessor of Medicine, Canada Research Chair, McGill UniversityAdresse e-mail validée de mcgill.ca
